RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @DrJoelGelfand: 42 new #psoriasis #pubmed hits this wk. A study of 434 patients who received anti-TNFα therapy after their initial #canc…
42 new #psoriasis #pubmed hits this wk. A study of 434 patients who received anti-TNFα therapy after their initial #cancer had a HR of new or recurrent cancer of 0·82 (95% CI 0·61 1·11). Reassuring data but uncertainty remains. #epitwitter https://t.co/L
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @evappampin: De nuevo datos relevantes para nuestra práctica diaria gracias a datos de los registros !!! https://t.co/BYTCJSidFz
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @WindermanMd: 👍🏻 Reassuring news Use of anti-TNFα therapy in IBD pts with h/o previous cancer ➡️ 🚫 a/w recurrence or new primary cance…
👍🏻 Reassuring news Use of anti-TNFα therapy in IBD pts with h/o previous cancer ➡️ 🚫 a/w recurrence or new primary cancer development Timing of therapy after initial cancer diagnosis 🚫 influence 👆🏻outcome The Lancet #medtwitter #gitwitter https://t.
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @Reumaclinic: Anti-TNF-α therapy and recurrent or new primary cancers in pts with IBD, RA or psoriasis & previous cancer 👉🏻Use of anti-T…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @Reumaclinic: Anti-TNF-α therapy and recurrent or new primary cancers in pts with IBD, RA or psoriasis & previous cancer 👉🏻Use of anti-T…
RT @ShirleyCoMekMD: Further reassurance of the safety of antiTNF therapy in #IBD and other autoimmune conditions. Great collaboration betwe…
RT @ShirleyCoMekMD: Further reassurance of the safety of antiTNF therapy in #IBD and other autoimmune conditions. Great collaboration betwe…
RT @ibddoctor: The conversation about the safety of therapy when #IBD flares after cancer therapy concludes can be difficult. I monitor for…
Further reassurance of the safety of antiTNF therapy in #IBD and other autoimmune conditions. Great collaboration between @UMichGIHep @AkbarWaljee @BethIWallace @ibddoctor and #TineJess and her team in Denmark
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @ibddoctor: The conversation about the safety of therapy when #IBD flares after cancer therapy concludes can be difficult. I monitor for…
RT @AlissonPuglies1: Should we use Anti TNF therapy in pts with previous cancer ? More data supporting no risk of recorrence or new cancer…
RT @ibddoctor: The conversation about the safety of therapy when #IBD flares after cancer therapy concludes can be difficult. I monitor for…
RT @evappampin: De nuevo datos relevantes para nuestra práctica diaria gracias a datos de los registros !!! https://t.co/BYTCJSidFz
RT @Reumaclinic: Anti-TNF-α therapy and recurrent or new primary cancers in pts with IBD, RA or psoriasis & previous cancer 👉🏻Use of anti-T…
RT @ibddoctor: The conversation about the safety of therapy when #IBD flares after cancer therapy concludes can be difficult. I monitor for…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @ibddoctor: The conversation about the safety of therapy when #IBD flares after cancer therapy concludes can be difficult. I monitor for…
The conversation about the safety of therapy when #IBD flares after cancer therapy concludes can be difficult. I monitor for the return of inflammation, and use gut-specific therapy as first line, but these data are reassuring if you need to go back to ant
RT @evappampin: De nuevo datos relevantes para nuestra práctica diaria gracias a datos de los registros !!! https://t.co/BYTCJSidFz
De nuevo datos relevantes para nuestra práctica diaria gracias a datos de los registros !!!
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @EricFMorand: wow this is a big one - safety (re cancer risk) of anti-TNF across inflammatory disease https://t.co/d1e4ky0Xb3
Anti-TNF-α therapy and recurrent or new primary cancers in pts with IBD, RA or psoriasis & previous cancer 👉🏻Use of anti-TNFα therapy was not associated with recurrent/new primary cancer development in pts with previous cancer. https://t.co/9WYaz1g1d
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @EricFMorand: wow this is a big one - safety (re cancer risk) of anti-TNF across inflammatory disease https://t.co/d1e4ky0Xb3
Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study https://t.co/aaQW780f34
RT @EricFMorand: wow this is a big one - safety (re cancer risk) of anti-TNF across inflammatory disease https://t.co/d1e4ky0Xb3
wow this is a big one - safety (re cancer risk) of anti-TNF across inflammatory disease
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
Should we use Anti TNF therapy in pts with previous cancer ? More data supporting no risk of recorrence or new cancer
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @LancetGastroHep: New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associa…
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
Chez un ancien cancéreux, en cas de maladie auto-immune de l'intestin, des articulations ou de la peau, les anti-TNF n'augmentent pas le risque de cancer https://t.co/e0c5LptQmz
RT @JeanDonet: Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cance…
Use of anti-TNFα therapy was not associated with recurrent or new primary cancer development in patients with previous cancer. Timing of anti-TNFα therapy after an initial cancer diagnosis did not influence recurrent or new primary cancer development. http
New Online: Use of anti-TNFα therapy for #inflammatoryboweldisease, #rheumatoidarthritis, or #psoriasis is not associated with development of recurrent or new primary #cancer in patients with previous cancer diagnosis - https://t.co/p63SbY3zwb @AkbarWaljee